Status:
RECRUITING
An Implementation Study of Suicide Risk Management Among Discharged Psychiatric Patients
Lead Sponsor:
Shenzhen Kangning Hospital
Conditions:
Suicide
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The post-discharge suicide risk among psychiatric patients is significantly higher than it among patients with other diseases and general population. The brief contact interventions (BCIs) are recomme...
Detailed Description
This is a mixed-methods study with two stages. The first stage is to develop the intervention strategy by individual in-depth and focus groups interviews; and the second stage is to implement the stra...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- For patients in the SMART trial and qualitative interviews
- Being 18 years and above;
- Being diagnosed with psychotic symptoms or MDD;
- Having received in-patient care for three days or more;
- Living in Shenzhen and having no plan to leave Shenzhen in the following 12 months after discharge;
- Being able to read text messages, answer phone calls on mobile phones, use WeChat or any application on smart phones.
- For lay health care supporters (LHSs) in qualitative interviews
- Being 18 years and above;
- Being without any diagnosis of mental disorder;
- Being the lay health care supporter in the family;
- Living in Shenzhen and having no plan to leave Shenzhen in the following 12 months after discharge;
- Being able to read text messages, answer phone calls on mobile phones, use WeChat or any application on smart phones.
- For the clinic and community mental health service providers in qualitative interviews
- Being 18 years and above;
- Having practiced in mental health service at least for 12 months.
- Exclusion criteria for patients in the SMART trial and qualitative interviews
- Unable to provide written consent due to any cognitive problems.
- Being discharged by the patient's or LHSs' demand against medical advice.
- With no ID, no stable residence nor any source of income.
Exclusion
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
624 Patients enrolled
Trial Details
Trial ID
NCT04907669
Start Date
January 1 2022
End Date
December 31 2025
Last Update
March 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shenzhen Kangning Hospital
Shenzhen, Guangdong, China, 518020